National HealthCare Corp. profits dip by 65 percent in 2026 Q3
National HealthCare Corp. reported a 65% dip in profits for the third quarter of 2026, totaling $14.2 million compared to $41 million in the same period of 2025. Despite this, adjusted net income saw a 13.8% increase, attributed to strategic acquisitions of skilled nursing facilities and independent living communities. The company remains confident in its liquidity, expecting to meet short-term obligations and growth plans through cash flow, current assets, and borrowing capacity.
National HealthCare (NHC) Earnings And Dividend Keep Valuation Questions In Play
National HealthCare (NHC) recently reported Q3 results with increased revenue but lower profit, while also confirming its upcoming cash dividend. The stock's valuation is complex, with a high price-to-earnings ratio of 28.5x suggesting overvaluation compared to peers, yet a discounted cash flow model indicates it is heavily undervalued. Investors are left to weigh these conflicting signals alongside strong historical shareholder returns and robust profit growth.
Will Revenue Growth With Lower Earnings Change National HealthCare (NHC) Narrative
National HealthCare Corporation reported increased revenue in Q3 2026 compared to the previous year, but experienced a significant drop in net income and diluted EPS, suggesting increased cost pressures. This performance may lead investors to re-evaluate the company's investment narrative, with a focus now on staffing, expenses, reimbursement trends, and cash allocation. Despite a recent earnings miss, the company's historical earnings growth and a P/E below the sector suggest some issues are already priced in, but share price sensitivity indicates ongoing margin concerns.
Form 8K National HealthCare Corp For: 6 November By Investing.com
This article reports that National HealthCare Corp (NHC) filed a Form 8K on November 6th. The filing is a standard SEC document used to announce significant events that investors should know about. No specific details of the 8K filing are provided in this brief announcement.
Form 8K National HealthCare Corp For: 6 November By Investing.com
National HealthCare Corp. (NHC) filed a Form 8K on November 6, 2026. This filing, a common regulatory disclosure for significant corporate events, indicates a material development for the company. The article provides the filing date and company information, noting a slight dip in NHC's stock price.
Revenue rose, but National HealthCare's net income fell to $13.6 million.
National HealthCare Corporation announced a 6.6% increase in net operating revenues for Q3 2026, reaching $407.97 million, up from $382.66 million in Q3 2025. Despite this revenue growth, GAAP net income attributable to NHC decreased significantly to $13.6 million ($0.85 diluted EPS) from $39.2 million ($2.50 diluted EPS) in the prior year, primarily due to unrealized losses on marketable equity securities and higher interest expenses. Adjusted net income, excluding these non-GAAP items, actually increased by 13.8% to $28.15 million, driven by recent acquisitions of skilled nursing and independent living facilities.
$408M in Q3 operating revenue, yet profit falls at National HealthCare (NHC).
National HealthCare Corporation (NHC) reported increased third-quarter 2026 operating revenues of $408.0 million and operating income of $40.6 million. However, net income attributable to NHC fell significantly to $13.6 million from $39.2 million in the prior year, primarily due to $17.6 million in net unrealized losses on marketable equity securities and higher interest expenses. The company also detailed several acquisitions of skilled nursing and independent living facilities, significantly increasing its total debt.
People who own National HealthCare shares on Dec. 31 will get 67 cents for each share.
National HealthCare Corporation (NHC) announced it will pay a quarterly dividend of 67 cents per common share. Shareholders of record on December 31, 2026, will receive the dividend on January 29, 2027. NHC, the oldest publicly traded long-term health care company, also included forward-looking statements regarding risks and uncertainties.
National HealthCare (NHC) Stock Looks About Right On Its 222% Run
National HealthCare (NHC) has seen a significant 222% stock price increase over the past five years, prompting questions about its current valuation. The stock trades at a P/E of 23.0x, slightly below the broader Healthcare sector and its peer group average, suggesting a potential discount. The article explores whether this valuation is justified by its earnings and future prospects, encouraging investors to consider underlying fundamentals and risk factors.
Three entities report National HealthCare (NHC) shares while disclaiming beneficial ownership.
First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation have jointly filed an amended ownership report for National HealthCare Corporation (NHC), each reporting beneficial ownership of 713,812 common shares, or 4.56% of the class. However, all three entities disclaim beneficial ownership of these shares. The report also specifies that shares held by unit investment trusts sponsored by First Trust Portfolios L.P. are voted by the trusts' trustee, not by the reporting parties, aligning with the voting patterns of other owners.
National HealthCare Corporation (NHC) Stock forecasts
Argus has lowered its target price for National HealthCare Corporation (NHC) to $233.00, citing the company's principal business in operating skilled nursing, assisted living, independent living facilities, and home care programs. NHC's current stock price is $206.14. The report provides a summary of NHC's business and recommends upgrading for premium screener tools and detailed company profiles.
National HealthCare Corp stock hits all-time high at 239.35 USD
National HealthCare Corp (NHC) stock reached an all-time high of $239.35, nearly doubling from its 52-week low and marking a 95.7% increase over the past year. Despite appearing overvalued by InvestingPro analysis, the company demonstrates financial stability with 23 consecutive years of dividend payments. This performance reflects strong investor confidence and successful strategic initiatives within the healthcare sector.
National HealthCare Corp stock hits all-time high at 239.35 USD
National HealthCare Corp (NHC) stock reached an all-time high of $239.35, nearly doubling from its 52-week low. Despite appearing overvalued by InvestingPro analysis, the stock has surged 95.7% over the past year, reflecting strong investor confidence and operational excellence. NHC has also maintained dividend payments for 23 consecutive years, showcasing financial stability.
National HealthCare Corporation (NHC) Stock Forecasts
Argus raised its target price for National HealthCare Corporation (NHC) to $251.00, while the stock's current price is $234.48. NHC primarily operates long-term care facilities, including skilled nursing, assisted living, independent living, and home care programs. The report also mentions other related analyst reports and market updates for different companies.
National HealthCare (NYSEAMERICAN:NHC) Stock Breaks Above 200-Day Moving Average - Time to Sell?
National HealthCare (NHC) stock recently broke above its 200-day moving average, trading at $228.27 after reaching a high of $231.94, significantly above the $201.54 average. The company reported quarterly EPS of $1.74 on $408.03 million in revenue and declared a $0.67 quarterly dividend. Despite institutional investment, including new positions from BlackRock and Morgan Stanley, insiders have sold nearly $4.0 million worth of shares in the past quarter.
National Healthcare Corp. Advanced Charts | HTW
This article provides advanced chart data and financial information for National Healthcare Corp. (HTW). It includes current stock performance metrics, analyst ratings, company overview, and key financial figures such as market value, EPS, and P/E ratio. The data sources and disclaimers for various financial information are also detailed.
23,008 Shares of National HealthCare Corporation $NHC Acquired by Bank of America Corp DE
Bank of America Corp DE acquired 23,008 shares of National HealthCare Corporation (NHC) during the second quarter, valued at approximately $4.86 million. This purchase represents about 0.15% of the company, with institutional investors collectively owning 56.44% of NHC stock. Despite significant institutional buying, company insiders sold 17,645 shares worth nearly $4.0 million over the past 90 days.
National healthcare sr. VP patient srvcs Dodson sells $1.09m stock
Vicki L. Dodson, Sr.VP Patient Srvcs at National Healthcare Corp (NASDAQ:NHC), sold 4,834 shares of company stock for approximately $1.09 million. Following this sale, Dodson retains over 10,700 shares directly and holds several options to purchase additional shares. This insider transaction occurred after NHC's acquisition of 35 healthcare facilities, aimed at enhancing earnings and cash flow.
Corient Private Wealth LP Raises Holdings in National HealthCare Corporation $NHC
Corient Private Wealth LP significantly increased its stake in National HealthCare Corporation (NHC) by 158.6% in the second quarter of 2026, bringing its total holdings to 11,825 shares valued at $2.499 million. This move is part of broader institutional interest, with BlackRock Inc. and Morgan Stanley also acquiring large positions. Despite recent insider selling, National HealthCare reported strong quarterly earnings and declared a dividend, maintaining a solid market presence.
National HealthCare (NYSEAMERICAN:NHC) VP Vicki Dodson Sells 4,834 Shares of Stock
National HealthCare (NYSEAMERICAN:NHC) VP Vicki Dodson sold 4,834 shares of the company's stock for $1,087,650 on September 22, 2026, reducing her holdings by 31.07%. Following the sale, Dodson now owns 10,726 shares valued at approximately $2,413,350. The company's shares are trading near their 12-month high, and National HealthCare recently announced a quarterly dividend of $0.67 per share.
National healthcare sr. VP patient srvcs Dodson sells $1.09m stock
Vicki L. Dodson, Sr.VP Patient Srvcs at National Healthcare Corp (NASDAQ:NHC), sold 4,834 shares of company stock for approximately $1.09 million. The sale occurred while NHC stock was trading near its 52-week high, with InvestingPro suggesting it is currently overvalued. This transaction follows National Healthcare Corporation's recent acquisition of 32 skilled nursing and three independent living facilities for $560 million from National Health Investors, Inc., a move expected to boost earnings and cash flow.
National HealthCare (NYSE: NHC) CFO sells stock at $225.70 a share
National HealthCare (NHC) Senior Vice President and CFO, Brian F. Kidd, sold 6,813 shares of common stock on September 11, 2026, at a price of $225.70 per share. Following this transaction, Kidd directly holds 23,183 common shares and multiple stock option awards. This insider sale was not conducted under a Rule 10b5-1 trading plan.
National Healthcare Corp (NHC) Insider Sale: CFO Brian Kidd Sells 6,813 Shares
Brian Kidd, CFO of National Healthcare Corp (NHC), sold 6,813 shares on September 11, 2026, marking his only selling activity in the past year. This transaction contributes to a broader insider selling trend, with 13 sells versus 1 buy over the last year. Coupled with NHC's significantly overvalued GF Value and high price-earnings ratio, investors are advised to exercise caution and consider the company's operational fundamentals and industry dynamics.
National HealthCare (NHC) insider sells shares near $225
National HealthCare's Senior VP & General Counsel, Josh A. McCreary, sold 2,719 shares of common stock on September 10, 2026, in open-market transactions at prices ranging from $222.73 to $225.59 per share. The sale was not conducted under a Rule 10b5-1 trading plan. Despite the sale, McCreary retains significant stock option holdings in the company.
National HealthCare (NYSE: NHC) officer plans stock sale under trading rule
An officer at National HealthCare (NHC), Josh A. McCreary, has filed a Form 144 notice to sell 2,719 shares of common stock, valued at approximately $600,817, through Janney Montgomery Scott on the NYSE. The shares originated from prior equity compensation, including restricted stock vesting and multiple stock option exercises. The filing also notes 15,661,395 NHC common shares outstanding as of September 10, 2026.
National HealthCare (NYSE: NHC) director sells 1,779 shares at $225
National HealthCare (NHC) director David R. Gifford sold 1,779 shares of company common stock on August 25, 2026, at a price of $225.42 per share, totaling approximately $401,000. Following this transaction, Gifford directly holds 1,030 shares of NHC. The sale was an open-market or private transaction and was not made under a Rule 10b5-1 trading plan.
National HealthCare (NYSE: NHC) director exercises 6,479 options, 4,691 shares withheld
NATIONAL HEALTHCARE CORP (NHC) director David R. Gifford exercised 6,479 stock options at $171.42 per share on August 20, 2026, receiving 6,479 common shares. Concurrently, 4,691 common shares were withheld by the company at $236.75 per share to cover the exercise price. These transactions, granted under the 2020 Omnibus Equity Incentive Plan, are exempt from Section 16(b).
National HealthCare (NYSEAMERICAN:NHC) Trading Down 2.8% After Insider Selling
National HealthCare (NHC) shares dropped 2.8% after CEO Stephen Fowler Flatt sold 1,500 shares for $355,620. This insider selling coincided with a 90% decrease in trading volume compared to the average session. Despite the insider activity, analysts maintain a "Buy" consensus rating for the company.
NHC CEO Stephen Flatt sells $355,620 in company shares
Stephen Flatt, CEO of National Healthcare Corp. (NASDAQ:NHC), sold 1,500 shares of the company's common stock for $355,620. This sale occurred as NHC stock is trading near its 52-week high, having delivered a 117% return over the past year. Following the transaction, Flatt directly holds 65,487 shares, in addition to various stock options.
National Healthcare Corp CEO Stephen Fowler Flatt Discloses Sale of 1,500 Shares
Stephen Fowler Flatt, CEO and Director of National Healthcare Corp (NYSE:NHC), sold 1,500 shares of company common stock on August 19, 2026, at $237.08 per share. After this transaction, Flatt directly owns 65,487 shares and holds 41,294 stock options across four tranches with varying exercise prices and expiration dates. This sale was disclosed via a Form 4 filing.
NHC CEO Stephen Flatt sells $355,620 in company shares
Stephen Flatt, CEO of National Healthcare Corp. (NASDAQ:NHC), sold 1,500 company shares for $355,620 on August 19, 2026. This transaction occurred while NHC stock was near its 52-week high, and an InvestingPro analysis suggests the stock is currently overvalued. Flatt retains 65,487 direct shares and various stock options following the sale.
National HealthCare (NYSE: NHC) CEO sells 1,500 shares in open-market trade
NATIONAL HEALTHCARE CORP (NHC) CEO Stephen Fowler Flatt sold 1,500 shares of common stock at $237.08 per share on August 19, 2026. Following this transaction, Flatt retains 65,487 directly held shares of common stock and several option awards. The sale was an open-market transaction, detailed in a recent SEC Form 4 filing.
Denali Advisors LLC Has $4.84 Million Position in National HealthCare Corporation $NHC
Denali Advisors LLC significantly increased its stake in National HealthCare Corporation (NHC) by 74.8% in the second quarter, now holding 22,900 shares valued at $4.84 million. Institutional investors collectively own 56.44% of NHC's stock, and analyst sentiment indicates a "Buy" consensus rating. NHC recently reported $408.03 million in quarterly revenue and a dividend of $0.67 per share.
National HealthCare Corp stock hits all-time high at 232.78 USD
National HealthCare Corp (NHC) stock has reached an all-time high of $232.78, reflecting a 115% increase over the past year. The company's market capitalization is now $3.6 billion, driven by strong investor confidence and recent strategic acquisitions. These acquisitions include 32 skilled nursing facilities and three independent living facilities from National Health Investors, Inc. for $560 million, and five more skilled nursing facilities for $50.5 million, which are expected to positively impact earnings and cash flow.
National HealthCare (NYSEAMERICAN:NHC) Shares Gap Down - Should You Sell?
National HealthCare (NHC) shares gapped down but recovered, opening at $209.33 from a prior close of $219.84, then trading around $222.03. Analysts have a "Buy" consensus rating for NHC, with two firms issuing "Strong Buy" and two "Hold" ratings. The company recently reported Q3 EPS of $1.74 on $408.03 million in revenue and declared a quarterly dividend of $0.67 per share, representing a 1.2% yield.
Form 8K National HealthCare Corp For: 11 August By Investing.com
This article reports on the filing of a Form 8K by National HealthCare Corp on August 11. It briefly mentions the company's stock performance (-1.97% for NHC) and includes a general market overview with various indices, commodities, and stock prices.
National HealthCare (NYSE: NHC) Q2 profit jumps as revenues rise and debt falls
National HealthCare Corporation reported significantly improved financial results for Q2 2026, with net operating revenues increasing by 8.8% to $408 million, largely due to a strategic acquisition of five skilled nursing facilities. The company also saw a substantial rise in GAAP net income and diluted EPS, while successfully eliminating all current and long-term debt, strengthening its balance sheet. NHC also increased its quarterly dividend per common share.
National HealthCare Corporation Announces Quarterly Dividend of $0.67 (NYSEAMERICAN:NHC)
National HealthCare Corporation (NHC) declared a quarterly dividend of $0.67 per share, payable on October 30, 2026, to shareholders of record by September 30, 2026. This dividend represents a 1.2% yield, and the company has consistently increased its dividend for the past decade. Analysts hold a "Buy" consensus rating for NHC, with shares opening at $219.45, near their 52-week high.
National HealthCare's June 1 Acquisition: Five Facilities, 639 Beds
National HealthCare Corporation (NHC) announced an 8.8% increase in net operating revenues to $408 million for the second quarter of 2026, primarily driven by the June 1 acquisition of five skilled nursing facilities with 639 beds in Tennessee and South Carolina. GAAP net income rose to $40.3 million from $23.7 million in Q2 2025, while adjusted net income increased by 7.2% to $27.5 million. The company reported GAAP diluted earnings per share of $2.54 and adjusted diluted EPS of $1.74 for the quarter.
Militia Capital Management LLC Acquires New Position in National HealthCare Corporation $NHC
Militia Capital Management LLC recently acquired a new position in National HealthCare Corporation (NHC), purchasing 17,700 shares valued at approximately $2.83 million. Institutional investors now collectively own 56.44% of NHC. The company reported strong quarterly earnings, raised its dividend, and analysts maintain a consensus "Buy" rating for the stock.
National HealthCare Corp stock hits all-time high at 232.67 USD
National HealthCare Corp (NHC) stock reached an all-time high of $232.67, representing a 142.71% surge over the past year. Despite trading above its Fair Value, the company shows strong financial health and strategic growth, including recent acquisitions of 32 skilled nursing facilities and three independent living facilities for $560 million, and five additional skilled nursing facilities for $50.5 million. These moves strengthen its operational footprint and are expected to boost earnings and cash flow.
National HealthCare Corp stock hits all-time high at 232.67 USD
National HealthCare Corp (NHC) stock reached an all-time high of $232.67, representing a 142.71% surge over the past year. Despite trading above its Fair Value, the company demonstrates robust financial health, expanded its operations through recent acquisitions of 32 skilled nursing and three independent living facilities for $560 million, and re-elected key board members. This growth solidifies its position as a significant entity in the healthcare sector.
National Healthcare Number of Employees 2026 | Employee Count & Headcount Data
National HealthCare Corp. (NHC) reported approximately 15,587 total employees worldwide as of March 2026, marking a 0.4% year-over-year increase. The company is actively hiring, with 2,243 active job postings in 2026, a 61.9% rise from 2025. Employee sentiment is negative and declining, while the workforce is concentrated in North America and primarily in Finance and Operations roles.
First Trust group (NYSE: NHC) discloses 5.09% beneficial stake in National HealthCare
First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation have jointly reported a 5.09% beneficial ownership stake in National HealthCare Corporation, totaling 795,771 shares as of June 30, 2026. The filing indicates shared dispositive power over these shares, with shared voting power over 780,661 shares, but the entities disclaim direct beneficial ownership as these holdings are primarily within unit investment trusts. Voting power for the unit investment trust shares is exercised by the trustee.
National Healthcare Corp (NHC) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides an event timeline and historical payout details for National Healthcare Corp (NHC) dividends and stock splits. It outlines various interim and final cash dividends with their respective dates, showing a total of $139.16 million distributed over the past five years. The page also includes current stock information such as market cap and P/E ratio.
NHC|National Healthcare Corp|Price:225.745|Chg%:+0.055
The article provides a comprehensive stock analysis of National Healthcare Corp (NHC) by TradingKey. It highlights NHC's strong fundamentals, high growth potential, and stable dividend payments, though notes its valuation is considered fairly valued and its PE ratio is currently overvalued. The analysis covers financial health, valuation, earnings forecast, price momentum, institutional confidence, and risk assessment, positioning NHC as a senior healthcare company with diverse operations across multiple states.
NHC|National Healthcare Corp|Price:225.560|Chg%:+4.050
This article provides a detailed financial overview and analysis of National Healthcare Corp (NHC), a senior healthcare company. It highlights NHC's strong fundamentals, high growth in revenue and net income, stable dividends, and current valuation status. The analysis suggests a potential upward trend in stock price despite technical indicators not fully supporting the current trend, positioning it for range-bound swing trading.
National Healthcare Corp (NHC) Institutional Confidence
National Healthcare Corp (NHC) has an institutional shareholding score of 7.00, placing it 37th out of 75 in the Healthcare Providers & Services industry. The institutional shareholding proportion has increased by 18.20% quarter-over-quarter to 73.95%. James Simons is the largest institutional shareholder, holding 2.15% of shares outstanding.
National Healthcare Corp (NHC) Shares Fall 3.6% -- What GF Score of 63 Tells Investors
National Healthcare Corp (NHC) saw its shares fall by 3.6%, leading to a current price of $219.88, significantly above its GF Value™ estimate of $128.80, indicating the stock is overvalued. Despite a strong Financial Strength rating of 9/10, its Valuation score is 1/10, suggesting caution for investors. Insider activity also shows significantly more selling than buying, raising questions about insider confidence in the stock's current price.
National HealthCare Corp stock hits all-time high at 219.05 USD
National HealthCare Corp (NHC) stock reached an all-time high of $219.05, currently trading at $218.80, just 1% below its 52-week high. The stock has seen a 109.92% increase over the past year, reflecting strong investor confidence despite being potentially overvalued according to InvestingPro data. The company recently expanded its portfolio by acquiring 32 skilled nursing facilities and three independent living facilities for $560 million, and an additional five skilled nursing facilities for $50.5 million.